Exhibition Recap | Setting Sail for New Horizons, Reuniting at 2024 ADLM!
The 2024 ADLM (76th American Association for Clinical Chemistry Annual Scientific Meeting & Clinical Lab Expo) was held from July 28 to August 1 in Chicago, USA. This grand event brought together over 800 exhibitors from around the world, showcasing the latest in clinical diagnostic equipment and technological solutions.
Our Sekbio team set sail and navigated through the waves to once again participate in the 2024 ADLM grand conference.
During the exhibition, we engaged in in-depth discussions with experts and scholars from across the globe, exploring the latest research findings and technological advancements. We also gained valuable insights into customer needs and industry trends. The event not only highlighted Sekbio's cutting-edge technology and products but also strengthened our connections and recognition with clients and partners.
Looking ahead, Sekbio remains committed to driving innovation and development in medical technology, aiming to enhance diagnostic accuracy and contribute significantly to global healthcare.
We extend our sincere thanks to all who support and follow Sekbio. We look forward to meeting you again at future exhibitions and events, exploring more exciting opportunities together!
Related Immunoassays
- Cardiac Markers
-
Tumor Marker
-
PGII
-
G17
- CA50
-
CA125
- CA242
-
CA15-3
- CA19-9
- CA72-4
-
Pepsinogens I (PGI)
-
Human Epididymis 4 (HE4)
- Prostate-Specific Antigen (PSA)
- Squamous Cell Carcinoma (SCC)
- Neuron-Specific Enolase (NSE)
- Cytokeratin 19 Fragment (CYFRA21-1)
- Human Progastrin-releasing Peptide (ProGRP Tumor Marker)
- Protein Induced by Vitamin K Absence or Antagonist-II (PIVKA II Tumor Marker)
- Alpha-fetoprotein(AFP)
-
CEA
-
Human Chitinase 3-like 1
-
PGII
- Inflammatory Marker
- Infectious Disease
- Hormones
- Thyroid Function
- Glucose Metabolism
- Bone Marker
- Others
-
Heterophilic Blocking Reagent
- Animal Diagnostics
